ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $536M

      Shares

      22.1M

      % of Portfolio

      0.39%

      Average Buy Price

      $127

      Avg closing price
      Price range

      27 Baillie Gifford Moderna Trades

      Baillie Gifford's position in Moderna is currently worth $536M. That's 0.39% of their equity portfolio (47th largest holding). The investor owns 5.72% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on thirteen occasions. The investor's estimated purchase price is $2.81B, resulting in a loss of 81%.

      Avg closing price
      Price range
      Sold 11.4% shares (-2.85M shares) Q2 2025
      Avg closing price $26.30
      Price range $23.65 - $28.54
      Sold 35.8% shares (-13.9M shares) Q1 2025
      Avg closing price $35.55
      Price range $28.35 - $47.53
      Sold 8.4% shares (-3.57M shares) Q4 2024
      Avg closing price $47.55
      Price range $36.85 - $63.93
      Sold 2.3% shares (-991k shares) Q3 2024
      Avg closing price $91.96
      Price range $63.64 - $125.14
      Sold 2.7% shares (-1.21M shares) Q2 2024
      Avg closing price $126.55
      Price range $101.21 - $166.61
      Sold 2.2% shares (-999k shares) Q1 2024
      Avg closing price $100.80
      Price range $85.37 - $115.44
      Increased shares by 0.0% (+5.34k shares) Q4 2023
      Avg closing price $84.11
      Price range $69.51 - $104.43
      Sold 0.1% shares (-61.9k shares) Q3 2023
      Avg closing price $111.55
      Price range $96.41 - $126.61
      Sold 1.6% shares (-755k shares) Q2 2023
      Avg closing price $133.40
      Price range $118.50 - $160.53
      Increased shares by 3.7% (+1.68M shares) Q1 2023
      Avg closing price $164.97
      Price range $135.66 - $197.02
      Sold 1.1% shares (-493k shares) Q4 2022
      Avg closing price $163.51
      Price range $118.38 - $210.04
      Sold 0.6% shares (-280k shares) Q3 2022
      Avg closing price $151.74
      Price range $118.07 - $194.18
      Sold 0.2% shares (-69.4k shares) Q2 2022
      Avg closing price $142.94
      Price range $117.13 - $176.59
      Sold 0.3% shares (-143k shares) Q1 2022
      Avg closing price $168.36
      Price range $126.46 - $235.05
      Increased shares by 8.4% (+3.55M shares) Q4 2021
      Avg closing price $292.38
      Price range $225.82 - $368.51
      Sold 8.0% shares (-3.67M shares) Q3 2021
      Avg closing price $368.80
      Price range $221.90 - $484.47
      Increased shares by 1.2% (+545k shares) Q2 2021
      Avg closing price $178.71
      Price range $129.91 - $234.98
      Increased shares by 86.5% (+21M shares) Q1 2021
      Avg closing price $144.91
      Price range $109.18 - $185.98
      Increased shares by 236.5% (+17.1M shares) Q4 2020
      Avg closing price $101.17
      Price range $65.74 - $169.86
      Increased shares by 78.0% (+3.17M shares) Q3 2020
      Avg closing price $69.72
      Price range $54.34 - $94.85

      News about Moderna Inc and Baillie Gifford

      Baillie Gifford Bolsters Stake in Moderna Inc

      Baillie Gifford Bolsters Stake in Moderna Inc

      Baillie Gifford Bolsters Stake in Moderna Inc

      GuruFocus GuruFocus, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×